Aurinia Pharmaceuticals (AUPH) Retained Earnings (2016 - 2026)
Aurinia Pharmaceuticals (AUPH) posted Retained Earnings of -$880000.0 for Q1 2026, up 99.86% on a QoQ basis from -$649.4 million in Q4 2025, and up 99.9% year-over-year from -$440212.1 in Q1 2025.
Aurinia Pharmaceuticals (AUPH) Retained Earnings (2016 - 2026) Analysis & Trends
Aurinia Pharmaceuticals' Retained Earnings history runs 11 years deep, the most recent figure standing at -$880000.0 for Q1 2026.
- Quarterly Retained Earnings rose 99.9% year-over-year to -$880000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$880000.0 (up 99.9% YoY) and the FY2025 annual result came in at -$649.4 million, up 30.67% from the prior year.
- Retained Earnings was -$880000.0 for Q1 2026 at Aurinia Pharmaceuticals, up from -$649.4 million in the prior quarter.
- Across five years, Retained Earnings topped out at -$749000.0 in Q3 2025 and bottomed at -$952.3 million in Q2 2024.
- A 5-year average of -$614.4 million and a median of -$838.3 million in 2022 frame the typical range for Retained Earnings.
- Peak annual rise in Retained Earnings reached 99.92% in 2025, while the deepest fall reached 106835.13% in 2025.
- Aurinia Pharmaceuticals' Retained Earnings stood at -$864.3 million in 2022, then slipped by 9.03% to -$942.3 million in 2023, then advanced by 0.61% to -$936.6 million in 2024, then soared by 30.67% to -$649.4 million in 2025, then soared by 99.86% to -$880000.0 in 2026.
- Business Quant data shows AUPH's Retained Earnings at -$880000.0 in Q1 2026, -$649.4 million in Q4 2025, and -$749000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Aurinia Pharmaceuticals | 2.02 Bn | 1.64 Bn | 71.20 Mn | -880,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -880,000.00 |
| Dec 31, 2025 | -649.37 Mn |
| Sep 30, 2025 | -749,000.00 |
| Jun 30, 2025 | -891.71 Mn |
| Mar 31, 2025 | -913.23 Mn |
| Dec 31, 2024 | -936.57 Mn |
| Sep 30, 2024 | -938.00 Mn |
| Jun 30, 2024 | -952.35 Mn |
| Mar 31, 2024 | -854,000.00 |
| Dec 31, 2023 | -942.32 Mn |
| Sep 30, 2023 | -947,000.00 |
| Jun 30, 2023 | -1.02 Mn |
| Mar 31, 2023 | -890.51 Mn |
| Dec 31, 2022 | -864.30 Mn |
| Sep 30, 2022 | -838.26 Mn |
| Jun 30, 2022 | -829.27 Mn |
| Mar 31, 2022 | -793.75 Mn |
| Dec 31, 2021 | -756.12 Mn |
| Sep 30, 2021 | -722.80 Mn |
| Jun 30, 2021 | -792,000.00 |